These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7067721)

  • 1. Isolation, characterisation and synthesis of a new quinidine metabolite.
    Guentert TW; Daly JJ; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):31-8. PubMed ID: 7067721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic method for the quantitation of quinidine and selected quinidine metabolites.
    Hoyer GL; Clawson DC; Brookshier LA; Nolan PE; Marcus FI
    J Chromatogr; 1991 Dec; 572(1-2):159-69. PubMed ID: 1818051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 10,11-dihydroxydihydroquinidine N-oxide, a new metabolite of quinidine. Preparation and 1H-nmr spectroscopy of the metabolites of quinine and quinidine and conformational analysis via 2D COSY nmr spectroscopy.
    Díaz-Araúzo H; Cook JM; Christie DJ
    J Nat Prod; 1990; 53(1):112-24. PubMed ID: 2348197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of quinidine and its major metabolites by high-performance liquid chromatography.
    Guentert TW; Coates PE; Upton RA; Combs DL; Riegelman S
    J Chromatogr; 1979 Jan; 162(1):59-70. PubMed ID: 762209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
    Nielsen F; Nielsen KK; Brøsen K
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):103-10. PubMed ID: 7858702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon-13 magnetic resonance study. Structure of the metabolites of orally administered quinidine in humans.
    Carroll FI; Smith D; Wall ME
    J Med Chem; 1974 Sep; 17(9):985-7. PubMed ID: 4412312
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT; Dzindzio BS
    Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of 1H-nuclear magnetic resonance spectroscopic method for quinidine to simultaneous determination of quinidine and dihydroquinidine in quinidine sulfate tablets.
    Hanna GM; Lau-Cam CA
    J Assoc Off Anal Chem; 1988; 71(6):1118-21. PubMed ID: 3240964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of quinidine and metabolites in urine by reverse-phase high-pressure liquid chromatography.
    Bonora MR; Guentert TW; Upton RA; Riegelman S
    Clin Chim Acta; 1979 Feb; 91(3):277-84. PubMed ID: 761404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of N-methyl-N'-oxonicotinium ion, a new urinary metabolite of R-(+)-nicotine in the guinea pig.
    Pool WF; Houdi AA; Damani LA; Layton WJ; Crooks PA
    Drug Metab Dispos; 1986; 14(5):574-9. PubMed ID: 2876864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
    Good SS; Koble CS; Crouch R; Johnson RL; Rideout JL; de Miranda P
    Drug Metab Dispos; 1990; 18(3):321-6. PubMed ID: 1974193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of quinidine and dihydroquinidine in humans.
    Hailey DM; Lea AR; Coles DM; Heaume PE; Smith WJ
    Eur J Clin Pharmacol; 1981; 21(3):195-9. PubMed ID: 7318878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the urinary metabolites of merbarone in cancer patients.
    Supko JG; Malspeis L
    Drug Metab Dispos; 1991; 19(1):263-73. PubMed ID: 1673412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA; Blair IA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):84-90. PubMed ID: 3572799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of quinidine analogs using ion-pairing HPLC.
    Al-Kaysi HN; Small LD; Murray WJ; Haddadin M
    J Chromatogr Sci; 1984 Feb; 22(2):80-3. PubMed ID: 6699121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum.
    Drayer DE; Lorenzo B; Reidenberg MM
    Clin Chem; 1981 Feb; 27(2):308-10. PubMed ID: 7006859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroquinidine contamination of quinidine raw materials and dosage forms: rapid estimation by high-performance liquid chromatography.
    Narang PK; Crouthamel WG
    J Pharm Sci; 1979 Jul; 68(7):917-9. PubMed ID: 458617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT
    Biochem Pharmacol; 1980 Mar; 29(5):737-40. PubMed ID: 20227949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.